DSGN Pangali Forward P/E Design Pharma
The visual price representation for Design Therapeutics (DSGN) on this page demonstrates the price action of an asset with a P/E ratio of 0.00. The business specializes in developing therapeutic agents through genome modification. The firm's growth depends on the outcomes of clinical trials for drugs targeting rare pathologies, ignoring market cycles. However, geopolitical barriers and trade bans on biomaterials significantly hinder the certification pace of new products.
Rincian metrik komprehensif lan analitis Design Corp (DSGN)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- informasi kapitalisasi buku:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Design Therapeutics|DSGN - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Design Therapeutics|DSGN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Design Therapeutics Inc|DSGN - Utang jangka dawa|Utang jangka cendhak perusahaan Design Therapeutics|Rasio cepet designtx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
DSGN - Bathi resik|Bathi sing dikarepake Design Therapeutics|DSGN - Kapitalisasi marang bathi resik|Pangali Forward P/E Design Pharma|DSGN - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Design Therapeutics Inc|DSGN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Design Therapeutics|DSGN - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan designtx.com|DSGN - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Design Therapeutics
Pambiji fundamental:Design Therapeutics, Inc.
Forward P/E determines the current stock value relative to expected earnings for the following year. This ratio allows an investor to assess market optimism and the premium paid for potential growth. By analyzing the forward P/E of a business, one can identify valuation deviations from fundamental trends. For Design Therapeutics (DSGN), this indicator depends critically on the success of small molecule clinical trials. High capital burn rates make earnings forecasts a determining factor of investment risk.
Pesaing Design Therapeutics (DSGN)
Pangali Forward P/E TEM|Kapitalisasi marang proyeksi bathi Qiagen NV|Pangali Forward P/E IONS (Ionis Pharma)|Pangali forward rega marang bathi Repligen Inc.|RNA - Rega marang bathi mangsa ngarep|CRSP (crisprtx.com) - Rasio rega marang bathi mangsa ngarep|WGS (GeneDx) - Prakiraan rega marang bathi|Ultragenyx Pharmaceutical Inc. - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi BEAM|SRPT (Sarepta Corp) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E TWST|TXG (10xgenomics.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E NTLA (Intellia Therapeutics, Inc.)|Stoke Therapeutics Inc (STOK) - Rasio prakiraan rega marang bathi|BLFS - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi WVE (Wave Pharma)|MAZE: Pangali Forward P/E|sionnatx.com (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine|Taysha Gene Therapies Inc - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E QURE|MGTX - Rasio prakiraan rega marang bathi|REGENXBIO Inc. - Prakiraan rega marang bathi|Pangali Forward P/E solidbio.com SLDB|OCGN: Prakiraan rega marang bathi|Pacific Biosciences of California, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|RCKT - Kapitalisasi marang proyeksi bathi|FDMT (4D Molecular Therapeutics) - Pangali Forward P/E|Prakiraan rega marang bathi Lexeo (LXEO)|Rega marang bathi mangsa ngarep Korro Bio, Inc. (KRRO)|Kapitalisasi marang proyeksi bathi Editas Medicine Inc|Pangali Forward P/E SLN (Silence Therapeutics Inc.)|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi sangamo.com SGMO|NAUT: Pangali Forward P/E|Pangali forward rega marang bathi Metagenomi Inc. MGX|Rega marang bathi mangsa ngarep Precision BioSciences, Inc.|Rasio rega marang bathi mangsa ngarep GBIO (Generation Bio Corp)|Pangali Forward P/E BOLD|exicuretx.com - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Imunon IMNN|PHIO: Rasio rega marang bathi mangsa ngarep|Mustang Bio Corp - Pangali Forward P/E|RNAZ - Pangali Forward P/E|BNGO: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep APDN|BLUE (bluebird bio) - Pangali Forward P/E|Rasio prakiraan rega marang bathi ImmunoPrecise IPA|Rega marang bathi mangsa ngarep Omega (OMGA)|Kapitalisasi marang proyeksi bathi Singular Genomics Corp|Pangali Forward P/E RGLS (Regulus Therapeutics)|Kapitalisasi marang proyeksi bathi syros.com (SYRS)|Telesis Bio - Pangali Forward P/E|Pangali forward rega marang bathi TRACON Pharmaceuticals Inc. (TCON)|Unity Bio (UBX) - Rega marang bathi mangsa ngarep
